Search by Drug Name or NDC
NDC 68180-0260-06 Divalproex sodium 250 mg/1 Details
Divalproex sodium 250 mg/1
Divalproex sodium is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is DIVALPROEX SODIUM.
MedlinePlus Drug Summary
Valproic acid is used alone or with other medications to treat certain types of seizures. Valproic acid is also used to treat mania (episodes of frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). It is also used to prevent migraine headaches but not to relieve headaches that have already begun. Valproic acid is in a class of medications called anticonvulsants. It works by increasing the amount of a certain natural substance in the brain.
Related Packages: 68180-0260-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Valproic Acid
Product Information
| NDC | 68180-0260 |
|---|---|
| Product ID | 68180-260_7b753d89-ac34-4feb-b573-302a1f3c1fca |
| Associated GPIs | 72500010107520 |
| GCN Sequence Number | 051469 |
| GCN Sequence Number Description | divalproex sodium TAB ER 24H 250 MG ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 18754 |
| HICL Sequence Number | 001884 |
| HICL Sequence Number Description | DIVALPROEX SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Divalproex sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Divalproex sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | DIVALPROEX SODIUM |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Pharmaceutical Class | Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209286 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68180-0260-06 (68180026006)
| NDC Package Code | 68180-260-06 |
|---|---|
| Billing NDC | 68180026006 |
| Package | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-260-06) |
| Marketing Start Date | 2020-09-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |